ALLR — Allarity Therapeutics Share News
0.000.00%
Last trade - 00:00- $13.77m
- $19.07m
- $0.32m
Brief: Allarity Therapeutics Files Prospectus Supplement To Increase Offering Price Of Common Stock That May Be Offered From $2.4 mln To $3.2 mln
Brief: Allarity To Focus On Accelerating Stenoparib Toward Regulatory Approval In Advanced Recurrent Ovarian Cancer
Brief: Oncology Firm Allarity Therapeutics Receives Extension From Nasdaq Hearings Panel To Regain Compliance With Listing Rules
Brief: Allarity Entered Into At-The-Market Issuance Sales Agreement With Ascendiant Capital Markets
Brief: Allarity Therapeutics Inc Says Entered Into At-The-Market Issuance Sales Agreement With Ascendiant Capital Markets
Swiss stocks - Factors to watch on February 2
Brief: Allarity Therapeutics On Jan 26 Received Notice From Novartis To Terminate Agreement
Brief: Allarity Therapeutics Inc - On Jan 18 Entered Into A Securities Purchase Agreement With 3I, Lp
Brief: Allarity Therapeutics Announces Thomas Jensen As Interim CEO
Brief: Allarity Therapeutics Says James Cullem Terminated As Chief Executive Officer
U.S. STOCKS ON THE MOVE-Enphase, Evolent Health, Procter & Gamble
U.S. STOCKS ON THE MOVE-G-III Apparel, AutoZone, Apple
U.S. STOCKS ON THE MOVE-CVS, JM Smucker, Fedex
Allarity Therapeutics up as lead drug shows clinical benefit in mid-stage trial
Brief: Allarity’S Early Phase 2 Stenoparib Data Indicates Clinical Benefit In Women With Advanced Ovarian Cancer Selected With Drp® Companion Diagnostic
Brief: Allarity Therapeutics Files For Shelf Of Up To 4.9 Million Shares Of Common Stock By Selling Stockholders - SEC Filing
U.S. STOCKS ON THE MOVE-Baxter International, Johnson & Johnson, Ford Motor
U.S. STOCKS ON THE MOVE-Hasbro, Sweetgreen, Innoviz Technologies
U.S. STOCKS ON THE MOVE-SoFi Technologies, Symbotic, Carnival